Investment Summary

Spring Mountain Capital Invests In Valorum Biologics

On January 1, 2025, growth capital firm Spring Mountain Capital invested in life science company Valorum Biologics

Investment Highlights
  • This is Spring Mountain Capital’s 8th transaction in the Life Science sector.
  • This is Spring Mountain Capital’s 27th transaction in the United States.
  • This is Spring Mountain Capital’s 5th transaction in New York.

Investment Summary

Date 2025-01-01
Target Valorum Biologics
Sector Life Science
Investor(s) Spring Mountain Capital
Deal Type Growth Capital

Target

Valorum Biologics

New York, New York, United States
Valorum Biologics develops and commercializes high‑value biosimilars for niche markets and serious diseases. Valorum Biologics is based in New York, New York.

Search 205,449 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

DESCRIPTION

Spring Mountain Capital is a growth capital firm focused on providing expansion capital to tech-enabled companies across North America. The Firm looks to invest in earlier stage companies ($2 to $20 million of revenue) with high growth rates, proven products/services, and a path to profitability. Spring Mountain generally looks to commit $5 to $15 million per transaction. Spring Mountain Capital was formed in 2001 and is based in New York City.


DEAL STATS #
Overall 29 of 29
Sector (Life Science) 8 of 8
Type (Growth Capital) 6 of 6
State (New York) 5 of 5
Country (United States) 27 of 27
Year (2025) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-09-04 Splash

New York, New York, United States

Splash is an event marketing technology company that helps businesses market, measure, and scale their event marketing programs. Splash is based in New York City.

Sell -